New oral anticoagulants-TURKey (NOAC-TURK): Multicenter cross-sectional study. - Wikidata - wikimedia - TriplyDB

New oral anticoagulants-TURKey (NOAC-TURK): Multicenter cross-sectional study.

New oral anticoagulants-TURKey (NOAC-TURK): Multicenter cross-sectional study.

http://www.wikidata.org/entity/Q33791997

about

Strengths and weaknesses of 'real-world' studies involving non-vitamin K antagonist oral anticoagulants.

P2860

Q55176626-95D268EA-1E48-47E8-9476-646C1205600B

P2860

New oral anticoagulants-TURKey (NOAC-TURK): Multicenter cross-sectional study.

http://www.wikidata.org/entity/Q33791997

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

New oral anticoagulants-TURKey (NOAC-TURK): Multicenter cross-sectional study.

@ast

New oral anticoagulants-TURKey (NOAC-TURK): Multicenter cross-sectional study.

@en

type

label

New oral anticoagulants-TURKey (NOAC-TURK): Multicenter cross-sectional study.

@ast

New oral anticoagulants-TURKey (NOAC-TURK): Multicenter cross-sectional study.

@en

prefLabel

New oral anticoagulants-TURKey (NOAC-TURK): Multicenter cross-sectional study.

@ast

New oral anticoagulants-TURKey (NOAC-TURK): Multicenter cross-sectional study.

@en

P1433

Q33791997-0F6FC8B0-0813-47BE-8DCF-9A4B4EF0D0D3

P1476

Q33791997-1ECCD616-DD69-4E75-9BA9-DDB89BA3B689

P2093

Q33791997-6BCB10B3-BC3C-4447-94EC-0D0F786C2708

Q33791997-87A45B34-3A61-4EB9-9DC2-479686B3D1D7

Q33791997-A97F7880-88D8-44FF-841C-760571345474

Q33791997-AD8C99E7-EEB5-4AE2-9136-B0149D4C7847

Q33791997-D046FE2F-4507-4B96-81E2-4F1A635FFE7D

Q33791997-ECB67C59-057C-4C8E-9D4F-82E2E66ADF26

Q33791997-EDF30007-CB83-49CA-9179-E1779DA83822

Q33791997-EE34E29D-A9A5-4B11-93E6-D940D5F24828

P2860

Q33791997-02559F51-1186-47CB-95A2-EBAE7188069C

Q33791997-16CDFD5F-F52B-4435-8B47-DD3EF350F83E

Q33791997-234DBB54-FA49-467A-ABAF-7ACE591116FC

Q33791997-253F6F02-3FA9-4548-9444-1079217F5AAD

Q33791997-2B88A8A0-AF54-466C-A916-4278511A3D2B

Q33791997-53EAF859-FD9E-48A6-A7D7-E98265716D5E

Q33791997-58D0DA5C-7C2B-4745-949E-841DA6279822

Q33791997-5D792FFC-B5F1-4AE4-AC19-6B6B32A4788A

Q33791997-7B0E8016-EF8E-44E1-96C1-25F020880BBE

Q33791997-877264B1-43A9-4666-8744-194C8E2ABE2B

P304

Q33791997-94EE572D-510A-434F-84E3-07A5661A849F

P31

Q33791997-7C676D7F-0AAC-4AA6-A0F1-EB59AFC864B5

P356

Q33791997-5A80DB05-E3DD-45B3-9452-9FC32927D5A4

P433

Q33791997-EF2B29AA-603A-4459-AD2D-C42555D457CA

P478

Q33791997-FCE956FD-D3B5-4016-94D9-5BE5489F49D2

P50

Q33791997-D1FCF712-DB27-4673-B538-8C97FB12A0FE

P577

Q33791997-0DB8F9D2-AC3E-4686-AAA7-8863690D14E3

P698

Q33791997-79D82C08-6166-4EA1-B3ED-61BCD357BD0F

P921

Q33791997-6D81D06D-C032-41D6-8108-DF68D8283424

Q33791997-A8B97A7A-5987-47C7-89AC-C5A381BB412C

P932

Q33791997-AE8C7855-C79A-481E-AF50-24ABF5E48204

P356

ANATOLJCARDIOL.2016.7472

P1433

Anatolian journal of cardiology

P1476

New oral anticoagulants-TURKey (NOAC-TURK): Multicenter cross-sectional study.

@en

P2093

Feyzullah Beşli

http://www.w3.org/2001/XMLSchema#string

Hüseyin Altuğ Çakmak

http://www.w3.org/2001/XMLSchema#string

Lütfü Aşkın

http://www.w3.org/2001/XMLSchema#string

NOAC-TURK Study Collaborators

http://www.w3.org/2001/XMLSchema#string

Ömer Gedikli

http://www.w3.org/2001/XMLSchema#string

Özge Özden Tok

http://www.w3.org/2001/XMLSchema#string

Özlem Yıldırımtürk

http://www.w3.org/2001/XMLSchema#string

Ümit Yaşar Sinan

http://www.w3.org/2001/XMLSchema#string

P2860

Dabigatran versus warfarin in patients with atrial fibrillation

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

Apixaban versus warfarin in patients with atrial fibrillation

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985-2009)

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study

Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF.

ReAl-life Multicenter Survey Evaluating Stroke prevention strategies in non-valvular atrial fibrillation (RAMSES study).

P304

353-361

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.14744/ANATOLJCARDIOL.2016.7472

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28100898

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

multicenter trial

P932

5469081

http://www.w3.org/2001/XMLSchema#string